China · Delayed Price · Currency is CNY Hybio Pharmaceutical Statistics
Total Valuation
SHE:300199 has a market cap or net worth of CNY 19.31 billion. The enterprise value is 20.99 billion.
| Market Cap | 19.31B |
| Enterprise Value | 20.99B |
Important Dates
The last earnings date was Tuesday, October 27, 2026.
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHE:300199 has 883.24 million shares outstanding. The number of shares has increased by 3.29% in one year.
| Current Share Class | 883.24M |
| Shares Outstanding | 883.24M |
| Shares Change (YoY) | +3.29% |
| Shares Change (QoQ) | +9.47% |
| Owned by Insiders (%) | 24.69% |
| Owned by Institutions (%) | 6.59% |
| Float | 652.21M |
Valuation Ratios
The trailing PE ratio is 49.70.
| PE Ratio | 49.70 |
| Forward PE | n/a |
| PS Ratio | 12.66 |
| PB Ratio | 17.78 |
| P/TBV Ratio | 25.59 |
| P/FCF Ratio | 1,307.88 |
| P/OCF Ratio | 56.53 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 34.97, with an EV/FCF ratio of 1,421.82.
| EV / Earnings | 52.23 |
| EV / Sales | 13.76 |
| EV / EBITDA | 34.97 |
| EV / EBIT | 43.55 |
| EV / FCF | 1,421.82 |
Financial Position
The company has a current ratio of 0.62, with a Debt / Equity ratio of 1.73.
| Current Ratio | 0.62 |
| Quick Ratio | 0.31 |
| Debt / Equity | 1.73 |
| Debt / EBITDA | 3.12 |
| Debt / FCF | 126.89 |
| Interest Coverage | 5.62 |
Financial Efficiency
Return on equity (ROE) is 45.60% and return on invested capital (ROIC) is 16.33%.
| Return on Equity (ROE) | 45.60% |
| Return on Assets (ROA) | 8.46% |
| Return on Invested Capital (ROIC) | 16.33% |
| Return on Capital Employed (ROCE) | 22.39% |
| Weighted Average Cost of Capital (WACC) | 7.71% |
| Revenue Per Employee | 1.24M |
| Profits Per Employee | 327,781 |
| Employee Count | 1,226 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 1.50 |
Taxes
In the past 12 months, SHE:300199 has paid 38.42 million in taxes.
| Income Tax | 38.42M |
| Effective Tax Rate | 8.77% |
Stock Price Statistics
The stock price has decreased by -1.93% in the last 52 weeks. The beta is 0.69, so SHE:300199's price volatility has been lower than the market average.
| Beta (5Y) | 0.69 |
| 52-Week Price Change | -1.93% |
| 50-Day Moving Average | 23.86 |
| 200-Day Moving Average | 21.68 |
| Relative Strength Index (RSI) | 38.00 |
| Average Volume (20 Days) | 57,179,246 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300199 had revenue of CNY 1.53 billion and earned 401.86 million in profits. Earnings per share was 0.44.
| Revenue | 1.53B |
| Gross Profit | 935.54M |
| Operating Income | 481.94M |
| Pretax Income | 437.87M |
| Net Income | 401.86M |
| EBITDA | 599.48M |
| EBIT | 481.94M |
| Earnings Per Share (EPS) | 0.44 |
Balance Sheet
The company has 205.63 million in cash and 1.87 billion in debt, with a net cash position of -1.67 billion or -1.89 per share.
| Cash & Cash Equivalents | 205.63M |
| Total Debt | 1.87B |
| Net Cash | -1.67B |
| Net Cash Per Share | -1.89 |
| Equity (Book Value) | 1.09B |
| Book Value Per Share | 1.16 |
| Working Capital | -681.19M |
Cash Flow
In the last 12 months, operating cash flow was 341.56 million and capital expenditures -326.79 million, giving a free cash flow of 14.76 million.
| Operating Cash Flow | 341.56M |
| Capital Expenditures | -326.79M |
| Depreciation & Amortization | 117.54M |
| Net Borrowing | 73.66M |
| Free Cash Flow | 14.76M |
| FCF Per Share | 0.02 |
Margins
Gross margin is 61.32%, with operating and profit margins of 31.59% and 26.34%.
| Gross Margin | 61.32% |
| Operating Margin | 31.59% |
| Pretax Margin | 28.70% |
| Profit Margin | 26.34% |
| EBITDA Margin | 39.30% |
| EBIT Margin | 31.59% |
| FCF Margin | 0.97% |
Dividends & Yields
SHE:300199 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 24.24% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.29% |
| Shareholder Yield | -3.29% |
| Earnings Yield | 2.01% |
| FCF Yield | 0.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 14, 2015. It was a forward split with a ratio of 2.
| Last Split Date | Apr 14, 2015 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |